Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
复制标题
Poly(U)结合剪接因子60通过转录上调端粒酶逆转录酶促进肾细胞癌生长
DOI:
10.7150/ijbs.45115
复制
发表时间:
2020
影响因子:
9.2
通讯作者:
Deng W
中科院分区:
文献类型:
--
作者:
Long Q;Hua Y;He L;Zhang C;Sui S;Li Y;Qiu H;Tian T;An X;Luo G;Yan Y;Zhao A;Shi D;Xie F;Chen M;Zheng F;Deng W
Background: Abnormal transcriptional upregulation of telomerase reverse transcriptase (TERT) plays a dominant role in telomerase activation in various cancers. TERT promoter mutations (TPMs) have been identified as a key mechanism in TERT upregulation. However, the mechanism of TERT upregulation in cancers with low frequency of TPMs are not fully elucidated so far. Methods: The expression of PUF60 and TERT was detected by real-time PCR, western blot and immunohistochemistry. TERT promoter binding proteins were identified by streptavidin-agarose pulldown assay and mass spectrum (MS) analysis. The role of PUF60/TERT in renal cancer was evaluated on cell growth in vitro and in vivo. Results: In this study, we identify the regulation mechanism of TERT in renal cell carcinoma (RCC) cells which have rare TPMs but exert significant upregulation of TERT. We found that TERT was highly expressed in RCC tumor tissues, and elevated TERT expression was associated with poor prognosis for patients. We also detected the relatively rare TPM status in both RCC tumor tissues and RCC cell lines. Mechanistically, PUF60, a RNA binding protein, was identified as a novel TERT regulator which bound to the TERT and transcriptionally upregulated TERT expression in RCC cells. The in vitro and in vivo experiments also demonstrated that PUF60 could promote RCC cell growth through activation of TERT expression in a TPM status independent way. Furthermore, we showed that there was a strong correlation of the expression of PUF60 and TERT in RCC tumor tissues and RCC cell lines, and the patients with high expression of PUF60 and TERT had significantly shorter survival. Conclusions: Collectively, these results indicated that PUF60 transcriptionally upregulated TERT expression to promote RCC growth and progression in a TPM status independent way, suggesting that the PUF60/TERT signaling pathway may serve as potential prognostic biomarkers and therapeutic targets for RCC.
登录
查看更多内容
DOI:
10.1056/nejmoa1407279
发表时间:
2015-06-25
期刊:
The New England journal of medicine
影响因子:
--
作者:
Eckel-Passow JE;Lachance DH;Molinaro AM;Walsh KM;Decker PA;Sicotte H;Pekmezci M;Rice T;Kosel ML;Smirnov IV;Sarkar G;Caron AA;Kollmeyer TM;Praska CE;Chada AR;Halder C;Hansen HM;McCoy LS;Bracci PM;Marshall R;Zheng S;Reis GF;Pico AR;O'Neill BP;Buckner JC;Giannini C;Huse JT;Perry A;Tihan T;Berger MS;Chang SM;Prados MD;Wiemels J;Wiencke JK;Wrensch MR;Jenkins RB
通讯作者:
Jenkins RB
影响因子:
11.2
作者:
Matsushita, K;Tomonaga, T;Ochiai, T
通讯作者:
Ochiai, T
影响因子:
23.4
作者:
Allory, Yves;Beukers, Willemien;Real, Francisco X.
通讯作者:
Real, Francisco X.
DOI:
10.1126/science.1229259
发表时间:
2013-02-22
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Huang FW;Hodis E;Xu MJ;Kryukov GV;Chin L;Garraway LA
通讯作者:
Garraway LA
影响因子:
16
作者:
Liu, JH;He, LS;Levens, D
通讯作者:
Levens, D